» Articles » PMID: 27890988

Variability in Proteinase-antiproteinase Balance, Nutritional Status, and Quality of Life in Stable Chronic Obstructive Pulmonary Disease Due to Tobacco and Nontobacco Etiology

Overview
Journal Lung India
Specialty Pulmonary Medicine
Date 2016 Nov 29
PMID 27890988
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Although the role of proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease (COPD) due to tobacco is well established, information in COPD due to nontobacco etiology is sparse.

Aims: To assess the variability in metalloproteinase activity in COPD related to tobacco and nontobacco causes.

Settings And Design: This is a hospital-based, prospective, observational study.

Subjects And Methods: Serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) were estimated in 200 subjects divided equally into four groups, i.e. COPD in tobacco smokers, COPD in nonsmokers but with exposure to biomass-related indoor air pollution, smokers without COPD, and nonsmoking healthy controls. Anthropometric skinfold measurements, quality of life (QOL) using St. George Respiratory Questionnaire, and exercise capacity using the 6-min walk test (6-MWT) were carried out. Groups were compared using analysis of variance and Kruskal-Wallis plus Mann-Whitney U-test to assess differences between groups. The Chi-square and Fisher's exact tests were used to evaluate associations among categorical variables. Spearman's rank correlation was calculated to assess the correlation between data.

Results: Patients with COPD due to either tobacco or nontobacco etiology were older, more malnourished, had worse QOL, and poorer exercise capacity compared to non-COPD subjects. Triceps, subscapular, and suprailiac skinfold thicknesses were less in smokers with COPD than biomass-related COPD. MMP-9 and TIMP-1 levels were similar across all groups. TIMP-1 significantly correlated with 6-MWT among all groups.

Conclusions: The protease-antiprotease balance in COPD is similar irrespective of the presence or absence of tobacco exposure but is related to poor exercise capacity.

Citing Articles

MicroRNA Let-7 Induces M2 Macrophage Polarization in COPD Emphysema Through the IL-6/STAT3 Pathway.

Liu T, Zhang Z, Shen W, Wu Y, Bian T Int J Chron Obstruct Pulmon Dis. 2023; 18:575-591.

PMID: 37077365 PMC: 10108876. DOI: 10.2147/COPD.S404850.


Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD Regulating DNMT1.

Zhang F, Guo F, Liu Y, Zhang Y, Li D, Yang H Front Pharmacol. 2022; 13:903593.

PMID: 35754478 PMC: 9214040. DOI: 10.3389/fphar.2022.903593.


Nonsmoker COPD: Is it a reality?.

Sharma B, Singh V Lung India. 2017; 34(2):117-119.

PMID: 28360456 PMC: 5351350. DOI: 10.4103/lungindia.lungindia_56_17.

References
1.
Snider G . Emphysema: the first two centuries--and beyond. A historical overview, with suggestions for future research: Part 2. Am Rev Respir Dis. 1992; 146(6):1615-22. DOI: 10.1164/ajrccm/146.6.1615. View

2.
Finlay G, Russell K, McMAHON K, DArcy E, Masterson J, Fitzgerald M . Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax. 1997; 52(6):502-6. PMC: 1758576. DOI: 10.1136/thx.52.6.502. View

3.
Finlay G, ODriscoll L, Russell K, DArcy E, Masterson J, Fitzgerald M . Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 1997; 156(1):240-7. DOI: 10.1164/ajrccm.156.1.9612018. View

4.
Belvisi M, Bottomley K . The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?. Inflamm Res. 2003; 52(3):95-100. DOI: 10.1007/s000110300020. View

5.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View